Columbia University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Columbia University sits in the top decile of US sponsors by registered trial count (#34 of 15,742 sponsors by registered trial count).
Columbia University: 958 sponsored US clinical trials, 171 recruiting.
Columbia University sponsors 958 registered US clinical trials on ClinicalTrials.gov, 171 of them currently recruiting, and 597 completed. 88 of these trials are in Phase 3-4 (later-stage) and 191 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 9 trials.
Top-decile sponsor footprint
Columbia University ranks in the top decile of sponsors by registered trial count (#34 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
597 of 736 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
958 total, page 17 of 20
Trial of Sorafenib in Hepatocellular Cancer (HCC) Transplant Patients
NCT00997022
Undiagnosed Diabetes in a Dental Setting
NCT01711385
Pancreatic Intraepithelial Neoplasia (PanIN) and the Association With Recurrence of Pancreatic Adenocarcinoma
NCT01219829
The Chronic Obstructive Pulmonary Disease Fish Oil Pilot Trial
NCT00835289
Validation of a Mouse Model of Pancreatic Carcinogenesis
NCT01103128
Effect of Oral Choline Supplementation on Postoperative Pain
NCT00720343
Neuroprotection With Statin Therapy for Acute Recovery Trial Phase 2
NCT01976936
Cognitive Dysfunction in Hypertensive Patients Having Spine Surgery
NCT01140854
Fresh Versus Old Red Blood Cells for Transfusion
NCT01319552
Intravesicular Abraxane for Treatment-Refractory Bladder Cancer
NCT00583349
P-glycoprotein Inhibition as Adjunct Treatment for Medically Refractory Epilepsy.
NCT00524134
Family and Personal History of Malignancy in Intraductal Papillary Mucinous Neoplasm (IPMN)
NCT01104077
Effect of Robot Rehabilitation Exercise Training on Motor Control After Stroke
NCT02331407
Prenatal Cytogenetic Diagnosis by Array-Based Copy Number Analysis
NCT01279733
Randomized Controlled Trial of Structured Contraceptive Counseling in Adult Women
NCT00746993
Feasibility of Delphi Screener for Cervical Cytology
NCT00702208
Northern Manhattan Diabetes Community Outreach Project
NCT00787475
Forteo for the Treatment of Unexplained Osteoporosis in Premenopausal Women
NCT00697463
Intracardiac T-wave Alternans and Ischemia
NCT00669552
T-wave Alternans and Intrathoracic Impedance Measurements
NCT00669682
Immediate Versus Delayed Insertion of the Copper Intrauterine Device (IUD) After Medication Abortion
NCT00737178
Metformin in Amnestic Mild Cognitive Impairment
NCT00620191
Family Nurture Intervention (FNI) in Neonatal Intensive Care Unit (NICU)
NCT01439269
Comparison of Serum Contraceptive Hormone Levels Between Normal Weight and Obese Users of the NuvaRing®
NCT00710606
Patient Outcomes in Simulation Education (POISE) Intravenous (IV) and Lumbar Puncture (LP) Multi-institution Protocol
NCT01548547
Phase I Vorinostat in Combination With Niacinamide and Etoposide for Lymphoid Malignancies
NCT00691210
Trial of Leptin Administration After Roux-en-Y Gastric Bypass
NCT00710814
Assessment of Cardiovascular Risk Markers in Growth Hormone Deficient Patients With Nonsecreting Pituitary Adenomas
NCT00646308
Comparision of Air Versus CO2 for Distention During Sigmoidoscopy
NCT00771290
Impact of Tachycardia on Outcome After Subarachnoid Hemorrhage (SAH)
NCT01585311
Effect of Proton Pump Inhibitors on CF Pulmonary Exacerbations
NCT01983774
Trimodal Lung-Sparing Treatment of Pleural Mesothelioma
NCT00859495
Polysomnography-directed Noninvasive Ventilation in Amyotrophic Lateral Sclerosis (ALS)
NCT01363882
Effects of Tolcapone on Frontotemporal Dementia
NCT00604591
Txt Now 2 Decrease Pregnancies L8r: A Study to Evaluate the Effect of Daily Text Message Reminders on Pill Continuation
NCT00677703
Feasibility Study of Simvastatin in Hodgkin's Lymphoma Survivors
NCT00746603
Differential Effects of rhGH vs. rhIGF-1 on Cardiovascular Risk Factors
NCT00684957
Training Cognitive Control Processes in Older Adults
NCT00586638
Phase I Dose-Escalation Study Of Azacitidine In Combination With Temozolomide
NCT00629343
Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders
NCT00801931
Pilot Study of Femring Estrogen Supplementation During Depo-Provera Initiation
NCT00563576
Effect of Noninvasive Ventilation on Lung Function in Amyotrophic Lateral Sclerosis
NCT00537446
Bone Marrow Cell Transplantation to Improve Heart Function in Individuals With End-Stage Heart Failure
NCT00383630
Improving Medication Adherence in Post-ACS Patients
NCT00576160
Post-treatment Care of Breast Cancer Survivors
NCT00821288
Pre-Surgical Intervention for Targeted Therapies for Breast Cancer
NCT01004744
Effects of Physical Activity and Dietary Change in Minority Breast Cancer Survivors
NCT00811824
The Impact of Pack Supply on Birth Control Pill Continuation
NCT00677742
Evaluating Long Acting Beta Agonists Used to Treat Asthma Among Those With Either Arg/Arg or Gly/Gly Genotypes
NCT00521222
The Effects of Leucine on Body Weight
NCT00683826
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 86 |
| Phase 2 | 105 |
| Phase 3 | 23 |
| Phase 4 | 65 |
Therapeutic Areas
What is open in the Columbia University pipeline
171 recruiting of 958 indexed (18% open); 597 completed (62%).
Phase mix: 88 late (III/IV) vs 191 early (I/II) (early-phase heavy).
Top condition: Obesity (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Columbia University: open-pipeline peers nationwide
Peers matched on 958 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Columbia University sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 958 trials (± recruiting share)
- University of Minnesota · 966 trials · 19% recruiting
- Brigham and Women's Hospital · 937 trials · 15% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- University of California, Los Angeles · 897 trials · 18% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Kite, A Gilead Company · 18% recruiting · 28 trials
- Mirum Pharmaceuticals · 18% recruiting · 28 trials
- West Virginia University · 18% recruiting · 122 trials
- Hospital for Special Surgery, New York · 18% recruiting · 194 trials
Related
What to do with this Columbia University page
958 registered trials is a research-attention snapshot, not an endorsement of Columbia University or any single study.
- 171 of Columbia University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Columbia University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Columbia University pipeline card: 958 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.